Fat accumulation in the liver unrelated to alcohol, now the most common chronic liver disease, affecting ~25% of adults. Driven by insulin resistance, refined carbs, and fructose. Highly reversible with low-carb diet, intermittent fasting, and targeted nutrients.
Last updated:
Non-Alcoholic Fatty Liver Disease (NAFLD), recently renamed MASLD (Metabolic dysfunction-Associated Steatotic Liver Disease), is excess fat accumulation in the liver (>5% by weight) that is NOT caused by significant alcohol consumption. It's now the most common chronic liver disease worldwide, affecting ~25% of all adults and ~70% of people with type 2 diabetes.
NAFLD is fundamentally a disease of metabolic dysfunction. Excess fructose, refined carbohydrates, and chronic insulin resistance drive fat (triglycerides) into liver cells. Once accumulated, this fat triggers inflammation, oxidative stress, and progressive liver damage. The condition is the hepatic manifestation of metabolic syndrome.
Here's the powerful news: NAFLD is one of the most reversible chronic diseases known. With targeted nutrition, particularly carbohydrate restriction, time-restricted eating, and addressing insulin resistance, liver fat can drop by 30-80% within weeks to months. Most patients can achieve resolution without medications.
Fat accumulation without inflammation. Asymptomatic. Reversible within weeks to months with dietary intervention. The vast majority of cases stay here, and aggressive lifestyle change resolves it.
Scar tissue forms, eventually replacing functional liver. Once cirrhosis is established, only ~20% of damage is reversible. Risk of liver failure, hepatocellular carcinoma, need for transplant. Early stages of fibrosis are still reversible with intensive intervention.
NAFLD is silent in early stages. Most diagnoses happen incidentally on routine bloodwork or imaging. Symptoms only appear with NASH or advanced disease, by which point significant damage has occurred.
Most common symptom in NAFLD. Persistent tiredness disproportionate to activity. Reflects mitochondrial dysfunction, chronic low-grade inflammation, and impaired liver metabolism. Often dismissed as "stress."
Vague achy fullness or pressure under the right rib cage. Reflects liver enlargement stretching its capsule. Often described as "I just feel a heaviness there." Not sharp pain (sharp = think gallbladder).
Visceral fat correlates strongly with liver fat, they accumulate together. Waist circumference >40" (men) or >35" (women) is a strong predictor of NAFLD even with "normal" BMI.
Compromised liver detoxification leads to subtle hepatic encephalopathy-like symptoms in advanced NAFLD: trouble concentrating, word-finding difficulty, mental cloudiness.
Yellow discoloration of skin or sclera (whites of eyes) indicates significant liver dysfunction. Late-stage sign suggesting advancement toward cirrhosis. Requires urgent evaluation.
Fluid accumulation in abdomen, sign of advanced cirrhosis with portal hypertension. Significant abdominal distention not from food or fat. Always evaluated as serious.
Liver makes clotting factors, failing liver impairs clotting. Easy bruising, prolonged bleeding from minor cuts, or unexplained bleeding indicates advanced disease.
Small spider-like blood vessels on skin (especially face/chest), reddened palms, both reflect estrogen elevation when liver can't metabolize hormones properly. Late-stage signs.
ALT (alanine aminotransferase) most specific for liver. Elevated ALT (>30 in men, >19 in women, even within "normal" range labs report) suggests liver fat. AST/ALT ratio >1 may indicate fibrosis. GGT also rises.
Non-invasive fibrosis score calculated from age, ALT, AST, platelets. <1.3 low risk for advanced fibrosis; >2.67 high risk. Easy to calculate from routine labs; should be done annually in anyone with risk factors.
Fasting insulin, HOMA-IR, HbA1c, lipid panel with triglycerides (often elevated), hsCRP. NAFLD almost always co-exists with insulin resistance, dyslipidemia, and inflammation.
Low-carb/keto diet, intermittent fasting, fructose elimination, weight loss, exercise, targeted liver support
NAFLD is overwhelmingly driven by dietary choices. Removing the inputs that cause it (refined carbs, fructose, processed food) allows the liver to reverse damage rapidly.
Salmon, sardines, mackerel. EPA/DHA reduce hepatic fat synthesis and inflammation. 3x/week minimum during reversal phase.
2-4 cups/day is consistently associated with lower NAFLD progression and reduced cirrhosis risk. Chlorogenic acid and caffeine both protective. Black or with minimal cream, no sugar.
Broccoli, cauliflower, kale, Brussels sprouts. Sulforaphane and indole-3-carbinol support liver Phase I/II detoxification.
Berries: low glycemic, antioxidant-rich; protective for liver. Extra-virgin olive oil: Mediterranean staple, reduces liver fat. Use generously.
Soda, fruit juice, sweetened coffee/tea, HFCS-laden foods. Fructose is metabolized ONLY by the liver, where it becomes fat. SINGLE BIGGEST NAFLD DRIVER. Even "natural" agave is 90% fructose.
White bread, pasta, rice, cereal, sweets. Spike insulin, drive hepatic de novo lipogenesis (fat creation). Replace with whole grains in moderation or skip during reversal phase.
Industrial seed oils, refined carbs, additives, advanced glycation end products. Each component damages the liver. Cleanest dietary lever: cut all foods with ingredient lists.
NAFLD is "non-alcoholic" but adding alcohol to a fatty liver dramatically accelerates damage. Eliminate during reversal; minimize permanently. Liver can only handle so much.
These supplements target hepatic fat reduction, insulin sensitivity, antioxidant defense, and gut-liver axis health.
| Supplement | Mechanism & Evidence | Suggested Dose | Timing | Notes |
|---|---|---|---|---|
| Berberine | Activates AMPK, reduces hepatic de novo lipogenesis, improves insulin sensitivity. Multiple meta-analyses show liver enzyme reduction, fat content reduction in NAFLD. | 500mg 2-3x/day | With meals | GI tolerance improves over 2 weeks. Don't combine with prescription diabetes meds without monitoring. |
| Vitamin E (mixed tocopherols) | Strongest single-agent evidence in biopsy-proven NASH (PIVENS trial). Reduces inflammation, oxidative damage, and modest fibrosis benefit. AASLD-recommended in non-diabetic NASH. | 800 IU/day | With fat meal | Natural mixed tocopherols superior to alpha-tocopherol alone. Avoid in patients on warfarin (consult prescriber). |
| Milk Thistle (Silymarin) | Hepatoprotective antioxidant. Modestly reduces ALT/AST in NAFLD. Long-standing safety record. Best as adjunct to dietary intervention. | 420mg/day standardized silymarin | With meals | Quality varies, choose standardized extracts (80% silymarin). |
| Omega-3 EPA/DHA | Reduces hepatic triglyceride accumulation, anti-inflammatory. Multiple meta-analyses support modest NAFLD benefit. | 2-4g combined EPA+DHA/day | With fat meal | Triglyceride form. IFOS-certified for purity. Especially valuable if elevated triglycerides. |
| Choline (Phosphatidylcholine) | Essential for VLDL formation, without choline, liver can't export fat. Deficiency directly causes NAFLD. Many people don't meet RDA. | 500-1,000mg/day | With meals | Eggs are richest dietary source. Sunflower lecithin is good supplement form. Especially important if low-egg diet. |
| N-Acetyl Cysteine (NAC) | Glutathione precursor. Modestly reduces liver enzymes and oxidative stress in NAFLD. Multi-mechanism antioxidant. | 600-1,200mg/day | Between meals | Can have sulfurous smell. Take with vitamin C for synergy. |
| Probiotic / Synbiotic | Gut-liver axis is central to NAFLD progression. Specific strains + prebiotic fiber reduce LPS translocation, improve insulin sensitivity, reduce liver enzymes. | Multi-strain 25-50 billion CFU + fermented foods | With meals | VSL#3 has most NAFLD-specific evidence. Combine with prebiotic fiber for synergy. |
| Vitamin D3 | Deficiency very common in NAFLD; supplementation improves insulin sensitivity and may modestly reduce liver fat. Standard repletion approach. | 2,000-5,000 IU/day | With fat meal | Test 25(OH)D; target 50-70 ng/mL. Always pair with K2. |
NAFLD is one of the most reversible chronic diseases. Within weeks of removing fructose and refined carbs, liver fat begins to drop. Most patients can fully resolve early NAFLD with sustained lifestyle change, no medications required.